by Cristina Sáez
A new study performed on mice by researchers from Spain and Canada has found that gut bacteria may play a role in protecting us from inflammatory bowel diseases (IBD) and specifically ulcerative colitis.
by Andreu Prados
A recent review article explores the role of the interactions between bacteria and fungi in Crohn’s disease and potential strategies to target the gut microbiota in gastrointestinal diseases.
by GMFH Editing Team
Gut Microbiota for Health is pleased to announce its participation at the 21st International Congress of Nutrition (ICN).
by GMFH Editing Team
A recent study has found that administration of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 may downregulate gut inflammatory genes in obese rats.
Here are our editors’ picks of some of the year’s most relevant developments in gut microbiome science, including topics that range from obesity and metabolic health to the gut-brain axis.
by Heather Galipeau
In a recently published paper in Nature Medicine, a group led by Harry Sokol at INRA studied how host genes affect the composition and function of the gut microbiota, and in turn, the production of metabolites and intestinal inflammation.
by Kristina Campbell
The observed success of the low-FODMAP diet in reducing gastrointestinal (GI) symptoms in IBS made a group of researchers ask whether the diet could also address functional GI symptoms in those with inflammatory bowel diseases (IBDs) such as Crohn's disease. This idea was explored in a recent study from the group at Monash University (Australia) that originally developed and tested the low-FODMAP diet.